Advertisement

Topics

GlaxoSmithKline Plc Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

22:26 EDT 4 Oct 2018 | BioPortfolio Reports

GlaxoSmithKline Plc Strategy, SWOT and Corporate Finance Report


Summary


GlaxoSmithKline Plc Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


GlaxoSmithKline plc GSK or 'the company' is a leading global provider of pharmaceuticals, vaccines and consumer healthcare products. It is primarily involved in developing, manufacturing and commercializing pharmaceuticals, vaccines and consumer healthcare products. These cater to the needs of HIV, respiratory, cancer, antivirals, metabolic, cardiovascular and urogenital, dermatology, antibacterials and several other rare diseases. It merchandise and sell these products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in England, the UK.


Scope


Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs

A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis

An indepth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments

Intelligence on GlaxoSmithKline Plc's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on GlaxoSmithKline Plc's business structure, strategy and prospects.

Original Article: GlaxoSmithKline Plc Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "GlaxoSmithKline Plc Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...